Výsledky vyhledávání - "Daciana Antal"

Maintenance Therapy with a Monthly Injection of Alemtuzumab Prolongs Response Duration in Patients with Refractory B-cell Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (B-CLL/SLL)

Autor: Daciana Antal, Fadhela Bouafia, Catherine Traulle, Catherine Thieblemont, Sophie Tartas, Charles Dumontet, Bernard Lemieux, Daniel Espinouse, Bertrand Coiffier, Emmanuel hornez, Gilles Salles

Publikováno v: Leukemia & Lymphoma. 45:711-714

Alemtuzumab, the monoclonal anti-CD52 antibody, has clinical activity in B-cell and T-cell malignancies at the dose of 30 mg three times weekly for 9-12 weeks. This standard regimen induced responses usually shorter than 6 months. To prolong time to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::765c63a188f69d69639c63b38c0b8868
https://doi.org/10.1080/10428190310001615675

Zobrazit plný text záznamu

Complete remission after first-line radiochemotherapy as predictor of survival in extranodal NK/T cell lymphoma

Autor: Bernadette Corront, Catherine Sebban, Gilles Salles, Hubert Orfeuvre, Daciana Antal, Françoise Berger, Anne-Sophie Michallet, Adrien Chauchet, Eric Deconinck, Marie Bouteloup, Tony Petrella, Isabelle Bedgedjian, Bertrand Coiffier, Maya Hacini

Publikováno v: Journal of Hematology and Oncology
Journal of Hematology and Oncology, BioMed Central, 2012, 5 (1), pp.27. ⟨10.1186/1756-8722-5-27⟩
Journal of Hematology & Oncology, Vol 5, Iss 1, p 27 (2012)
Journal of Hematology & Oncology

Background Extranodal nasal-type NK/T-cell lymphoma is a rare and severe disease. Considering the rarity of this lymphoma in Europe, we conducted a multicentric retrospective study on nasal-type NK/T cell lymphoma to determine the optimal induction s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3adce0a5f589044ca445622a4ec2b765
https://www.hal.inserm.fr/inserm-00722723

Zobrazit plný text záznamu

Autologous hematopoietic stem cell transplantation for adults with acute myeloid leukemia in complete remission: the Edouard Herriot Hospital experience

Autor: Xavier Thomas, Anne-Sophie Michallet, Franck E. Nicolini, Mauricette Michallet, Youcef Chelghoum, Anne Thiebaut, Jacques Troncy, Emmanuelle Tavernier, Thomas Prebet, Quoc-Hung Le, Mohamed Elhamri, Daciana Antal

Publikováno v: Hematology (Amsterdam, Netherlands). 11(3)

We retrospectively assess the long-term outcome and determined prognostic factors correlated with outcomes in adults with acute myeloid leukemia (AML) undergoing autologous hematopoietic stem cell transplantation (HSCT) in our institution over a 19-y

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b97fe7d696e7bd87777041cfd93333a
https://pubmed.ncbi.nlm.nih.gov/17325955

Zobrazit plný text záznamu

Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma

Autor: François Guilhot, Catherine Thieblemont, Christine Giraud, Daciana Antal, Fadhela Bouafia-Sauvy, Bertrand Coiffier, Laurence Lacotte-Thierry, Gilles Salles, Anne-Sophie Michallet, Vincent Delwail, Catherine Traulle, Daniel Espinouse

Publikováno v: Cancer. 104(7)

BACKGROUND The authors evaluated the efficacy of chemotherapy combined with rituximab followed by high-dose therapy (HDT) plus autologous stem cell transplantation in patients with mantle cell lymphoma (MCL). METHODS This was a retrospective analysis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::684e596d5ddf10cfb8ef174edd732e3c
https://pubmed.ncbi.nlm.nih.gov/16104036

Zobrazit plný text záznamu

Complete Remission After First-Line Radio Plus Chemotherapy Is Enough to Improve Survival in Extra Nodal NK/T Cell lymphoma

Autor: Adrien Chauchet, Gilles Salles, Anne-Sophie Michallet, Eric Deconinck, Marie Bouteloup, Tony Petrella, Francoise Berger, H. Orfeuvre, Bernadette Corront, Catherine Sebban, Maya Hacini, Isabelle Bedgedjian, Daciana Antal, Bertrand Coiffier

Publikováno v: Blood. 118:2679-2679

Abstract 2679 Extranodal nasal type NK/T-cell lymphoma (ENKTL) is a rare and severe disease, more frequent in Asia and South America. Previous studies showed that the 5-year overall survival (OS) rate was less than 40%, with a progression occurrence

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::908e2ec7669d4e812a1649e1f78150e5
https://doi.org/10.1182/blood.v118.21.2679.2679

Zobrazit plný text záznamu

Akademický článek

Chemotherapy with rituximab followed by high‐dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma.

Autor: Catherine Thieblemont, Daciana Antal, Laurence Lacotte‐Thierry, Vincent Delwail, Daniel Espinouse, Anne‐Sophie Michallet, Catherine Traulle, Fadhela Bouafia‐Sauvy, Christine Giraud, Gilles Salles, François Guilhot, Bertrand Coiffier

Publikováno v: Cancer (0008543X); Oct2005, Vol. 104 Issue 7, p1434-1441, 8p

Zobrazit plný text záznamu

Rituximab/chemotherapy induction treatment followed by high-dose therapy and autologous transplantation in patients with mantle cell lymphoma

Autor: Catherine Thieblemont, Gilles Salles, Sophie Tartas, Daniel Espinouse, Anne-Sophie Michallet, Daciana Antal, C. Giraud, B. Coiffier, Vincent Delwail, Laurence Lacotte-Thierry, François Guilhot, Fadhela Bouafia

Publikováno v: Publons

Between September 1998 and September 2003, 25 patients with Mantle Cell Lymphoma (MCL) were treated in our centres with a treatment combining rituximab + chemotherapy at induction with subsequent consolidation high-dose chemo/radiotherapy (HDT) and a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1be431955503af10fe3bdbfb82528c19
https://publons.com/publon/26049699/

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání